Study Stopped
Study not required due to change in device
Vent Flow Study of Prototype Nasal CPAP Mask
GVFECT
Long Term Vent Flow Study of Prototype Nasal CPAP Mask System
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
As continuous positive airway pressure is the treatment choice for OSA, a mask is vital in ensuring the effectiveness of therapy delivery. The study will evaluate the performance of a new mask system with diffuse vent technology. This is done by characterizing the mask flow over time and compare the performance between patients who apply 2 different washing procedures to the mask. The study will also subjectively assess breathing comfort and performance of the mask system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2016
CompletedFirst Posted
Study publicly available on registry
June 20, 2016
CompletedStudy Start
First participant enrolled
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedFebruary 4, 2021
February 1, 2021
7 months
June 1, 2016
February 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in vent flow of the mask system, which will be recorded on a flow testing rig (units= LPM). Baseline flow in LPM will be compared to that at the conclusion of the trial.
The mask system will be flow tested after use when returned by the participant at each scheduled visit. The flow of the mask system will be recorded as per the mask to flow procedure of ISO17510 Sleep apnoea breathing therapy - Part 2: Annex B Exhaust flow test procedure. The results will be reported as an average flow in LPM. Results will be presented graphically with average flow on the vertical axis and use time (weeks) on the horizontal axis. This will allow us to assess any changes in vent flow over time.
12 weeks
Secondary Outcomes (3)
Parameters such as the apnoea/hypopnoea index (AHI) will be recorded and analysed
12 weeks
Questionnaire to assess the perceived overall performance of the mask by the participant. Questions around comfort will be asked.
12 weeks
Bioburden quantification by laboratory testing of venting components at end of trial
12 weeks
Study Arms (2)
Washing procedure 1
EXPERIMENTALthis group will apply washing technique 1
Washing procedure 2
EXPERIMENTALthis group will apply washing technique 2
Interventions
A new vent CPAP mask system will be used in this trial
Eligibility Criteria
You may qualify if:
- Participants willing to give written informed consent
- Participants who can read and comprehend English
- Participants using APAP for \>6 months
- Participants who are willing to use the mask system for the 3 month duration of the trial.
- Participants who are over 18 years of age
- Participants who currently use a nasal mask system
You may not qualify if:
- Participants not willing to give written informed consent
- Participants who cannot read and comprehend English
- Participants using an inappropriate mask system
- Participants on a Bilevel or ASV therapy
- Participants who are pregnant
- Participants with a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer lung injury; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection
- Participants or whose bed partner with implantable metallic implants in the head, neck and chest region affected by magmetic fields (Non-ferrous implants may be acceptable)
- Participants that weight \<30 kg
- Participants who are unsuitable to participate in the study in the opinion of the researcher
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ResMedlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klaus Schindhelm, PhD
ResMed/The University of New South Wales
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2016
First Posted
June 20, 2016
Study Start
May 1, 2017
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
February 4, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share
There is no sharing plan.